Literature DB >> 22314298

Cardiac amyloidosis: what are the indications for transplant?

Scott H Bradshaw1, John P Veinot.   

Abstract

PURPOSE OF REVIEW: We review the clinical and pathological features of the various types of amyloid that involve the heart, the diagnostic utility of endomyocardial biopsy, and the experience of patient survival and disease recurrence following cardiac transplant for amyloidosis. RECENT
FINDINGS: Patient outcome is dependent on arresting the cause of amyloid as well as controlling the accumulated damage, which may involve multiple organs. As such, the stratification of patient suitability for cardiac transplant must be considered in conjunction with concurrent treatments, which may include autologous stem cell, liver or kidney transplant, and chemotherapy.
SUMMARY: As the efficacy of these therapies changes, the indications for cardiac transplantation need to be re-evaluated.

Entities:  

Mesh:

Year:  2012        PMID: 22314298     DOI: 10.1097/HCO.0b013e32834fdc7e

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  3 in total

Review 1.  Outcomes of heart transplantation in cardiac amyloidosis: an updated systematic review.

Authors:  Sofia Lakhdar; Chandan Buttar; Mahmood Nassar; Camelia Ciobanu; Rima Patel; Most Sirajum Munira
Journal:  Heart Fail Rev       Date:  2022-05-20       Impact factor: 4.654

Review 2.  Heart transplantation in cardiac amyloidosis.

Authors:  Matthew Sousa; Gregory Monohan; Navin Rajagopalan; Alla Grigorian; Maya Guglin
Journal:  Heart Fail Rev       Date:  2017-05       Impact factor: 4.214

3.  Morphologic features of the recipient heart in patients having cardiac transplantation and analysis of the congruence or incongruence between the clinical and morphologic diagnoses.

Authors:  William C Roberts; Carey Camille Roberts; Jong Mi Ko; Giovanni Filardo; John Edward Capehart; Shelley Anne Hall
Journal:  Medicine (Baltimore)       Date:  2014-07       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.